Sandbox: ATL

Revision as of 19:56, 24 January 2016 by Haytham Allaham (talk | contribs)
Jump to navigation Jump to search

[1][2][3]


prognosis

high lactate dehydrogenase (LDH) high β2‐microglobulin

high serum level of CD25 high serum neuron‐specific enolase

Prognostic Factor Description
Clinical form
  • Older age at the time of diagnosis is associated with a worse prognosis.
Age
  • Males are associated with a worse prognosis when compared to females.
Performance status
Calcium level
  • Binet stages B and C or Rai stages 2-4 are associated with a worse prognosis.
Leukocyte count
  • A rapid lymphocyte doubling time is associated with a worse prognosis.
Lactate dehydrogenase level
β2-microglobulin level
  • An increased percentage of prolymphocytes is associated with a worse prongnosis.
Histological analysis
Lactate dehydrogenase (LDH) level
  • Elevated level of LDH is associated with a worse prognosis.
β2-microglobulin level
  • Elevated level of β2-microglobulin level is associated with a worse prognosis.
Lymphocyte surface markers
  • Over expression of CD25 is associated with a worse prognosis.
Neuron‐specific enolase
  • The absence of IgVH gene mutation is associated with a worse prognosis.
Membrane-bound proteins
  • The expression of zeta-chain-associated protein kinase 70 (ZAP) is associated with a worse prognosis.
  1. Mahieux R, Gessain A (2007). "Adult T-cell leukemia/lymphoma and HTLV-1". Curr Hematol Malig Rep. 2 (4): 257–64. doi:10.1007/s11899-007-0035-x. PMID 20425378.
  2. Matutes E (2007). "Adult T-cell leukaemia/lymphoma". J Clin Pathol. 60 (12): 1373–7. doi:10.1136/jcp.2007.052456. PMC 2095573. PMID 18042693.
  3. Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y; et al. (2015). "Treatment and survival among 1594 patients with ATL". Blood. 126 (24): 2570–7. doi:10.1182/blood-2015-03-632489. PMID 26361794.